[
  {
    "title": "Why Novo Nordisk missed its sales estimates on weight-loss drug Wegovy: CEO",
    "link": "https://finance.yahoo.com/news/why-novo-nordisk-missed-its-sales-estimates-on-weight-loss-drug-wegovy-ceo-164318940.html"
  },
  {
    "title": "Novo Nordisk beats on Q1 earnings, cuts 2025 outlook",
    "link": "https://finance.yahoo.com/news/novo-nordisk-beats-on-q1-earnings-cuts-2025-outlook-105011679.html"
  },
  {
    "title": "Eli Lilly and Company (LLY): A Bull Case Theory",
    "link": "https://finance.yahoo.com/news/eli-lilly-company-lly-bull-171727157.html"
  },
  {
    "title": "Novo Nordisk Q1 Earnings Match Estimates, Revenues Rise Y/Y, Stock Up",
    "link": "https://finance.yahoo.com/news/novo-nordisk-q1-earnings-match-142900915.html"
  },
  {
    "title": "Jim Cramer Says Eli Lilly and Company (LLY) CEO David Ricks Is ‘Very Conservative’",
    "link": "https://finance.yahoo.com/news/jim-cramer-says-eli-lilly-142423163.html"
  },
  {
    "title": "Novo Nordisk Stock Jumps After Earnings. Compounding Market’s Growth Took it By Surprise",
    "link": "https://finance.yahoo.com/m/761a85ae-7e36-3fd3-a6f2-64763ae3ba70/novo-nordisk-stock-jumps.html"
  },
  {
    "title": "Company News for May 7, 2025",
    "link": "https://finance.yahoo.com/news/company-news-may-7-2025-132800349.html"
  },
  {
    "title": "Trump Is Threatening Big Pharma With Tariffs. Tax Changes Might Work Better.",
    "link": "https://finance.yahoo.com/m/a4bec800-6f4b-30e9-8edf-e6305a9166c4/trump-is-threatening-big.html"
  },
  {
    "title": "Eli Lilly (NYSE:LLY) Declares US$1.50 Second Quarter Dividend For 2025",
    "link": "https://finance.yahoo.com/news/eli-lilly-nyse-lly-declares-174911638.html"
  },
  {
    "title": "Trump Sets Pharma Tariffs Deadline. The Fallout for Lilly, Pfizer, Other Drugmakers.",
    "link": "https://finance.yahoo.com/m/4905bd6c-d6c2-31c3-8bdf-25145b8cfb69/trump-sets-pharma-tariffs.html"
  },
  {
    "title": "Eli Lilly signs $415m deal for Alchemab’s ALS therapy",
    "link": "https://finance.yahoo.com/news/eli-lilly-signs-415m-deal-163807154.html"
  },
  {
    "title": "Eli Lilly Stock Slips on Outlook. Is It Time to Buy the Dip?",
    "link": "https://finance.yahoo.com/news/eli-lilly-stock-slips-outlook-140000811.html"
  },
  {
    "title": "Mutual Funds Gobble Up Eli Lilly Stock, Ge Vernova And A Wrestling Name",
    "link": "https://finance.yahoo.com/m/8ab82a95-3c91-38aa-a350-bb1eb84a08b2/mutual-funds-gobble-up-eli.html"
  },
  {
    "title": "Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks",
    "link": "https://finance.yahoo.com/m/6c5668d6-05c3-37a6-8af6-c6146e6b299b/stocks-to-buy-and-watch-top.html"
  },
  {
    "title": "Bluebird pleads for deal support; Unity, Mersana lay off staff",
    "link": "https://finance.yahoo.com/news/bluebird-pleads-deal-support-unity-101900344.html"
  },
  {
    "title": "2 Mega-Cap Stocks with Solid Fundamentals and 1 to Keep Off Your Radar",
    "link": "https://finance.yahoo.com/news/2-mega-cap-stocks-solid-043633449.html"
  },
  {
    "title": "Lilly declares second-quarter 2025 dividend",
    "link": "https://finance.yahoo.com/news/lilly-declares-second-quarter-2025-164700818.html"
  },
  {
    "title": "Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know",
    "link": "https://finance.yahoo.com/news/investors-heavily-search-eli-lilly-130014274.html"
  },
  {
    "title": "With compounders out of the way, Lilly and Novo go after each other",
    "link": "https://finance.yahoo.com/news/compounders-way-lilly-novo-other-070528387.html"
  },
  {
    "title": "Eli Lilly First Quarter 2025 Earnings: EPS Misses Expectations",
    "link": "https://finance.yahoo.com/news/eli-lilly-first-quarter-2025-141048396.html"
  },
  {
    "title": "What is CVS? 'We are ... working through that very question'",
    "link": "https://finance.yahoo.com/news/what-is-cvs-we-are--working-through-that-very-question-133003590.html"
  },
  {
    "title": "Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?",
    "link": "https://finance.yahoo.com/news/trump-administration-cause-abbvie-eli-084900783.html"
  },
  {
    "title": "Investing.com’s stocks of the week",
    "link": "https://finance.yahoo.com/news/investing-com-stocks-week-093002217.html"
  },
  {
    "title": "Novo Nordisk shares jump as FDA accepts oral Wegovy application",
    "link": "https://finance.yahoo.com/news/novo-nordisk-shares-jump-fda-194836291.html"
  },
  {
    "title": "US FDA accepts Novo Nordisk's application for oral Wegovy for weight loss",
    "link": "https://finance.yahoo.com/news/us-fda-accepts-novo-nordisks-184103062.html"
  },
  {
    "title": "These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Two Top Buy Point",
    "link": "https://finance.yahoo.com/m/2b47c372-177e-3051-aa01-406a8d82b220/these-7-stocks-are-analyst.html"
  },
  {
    "title": "Eli Lilly (NYSE:LLY) Announces Promising Trial Data And Updates 2025 Guidance",
    "link": "https://finance.yahoo.com/news/eli-lilly-nyse-lly-announces-174607932.html"
  },
  {
    "title": "Trump Says Drug Tariffs Are Coming. Big Pharma Execs Can’t Figure Out How Much to Worry.",
    "link": "https://finance.yahoo.com/m/64ec4ca8-6882-3966-87c1-a6c7fec387aa/trump-says-drug-tariffs-are.html"
  },
  {
    "title": "Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday",
    "link": "https://finance.yahoo.com/news/why-eli-lilly-viking-therapeutics-155545062.html"
  },
  {
    "title": "Eli Lilly’s Stock Selloff Is Overdone, Analysts Say. Here’s Why.",
    "link": "https://finance.yahoo.com/m/bbeeee31-0cab-36da-b0c1-1bcee50f84f1/eli-lilly%E2%80%99s-stock-selloff-is.html"
  },
  {
    "title": "Eli Lilly's Zepbound Likely to Continue Uptake Despite CVS Decision, Truist Says",
    "link": "https://finance.yahoo.com/news/eli-lilly-apos-zepbound-likely-151239228.html"
  },
  {
    "title": "Eli Lilly Bounces Back. Zepbound Taking A Back Seat To Novo Nordisk's Wegovy At CVS.",
    "link": "https://finance.yahoo.com/m/e4d3bb24-9866-32c8-a5cd-88be4b1110b2/eli-lilly-bounces-back-.html"
  },
  {
    "title": "Eli Lilly stock sell-off was 'overreaction': Analysts",
    "link": "https://finance.yahoo.com/news/eli-lilly-stock-sell-off-was-overreaction-analysts-141331064.html"
  },
  {
    "title": "Lilly to participate in Bank of America Securities 2025 Healthcare Conference",
    "link": "https://finance.yahoo.com/news/lilly-participate-bank-america-securities-140000300.html"
  },
  {
    "title": "Update: Eli Lilly Brushes Off CVS Decision to Drop Zepbound Coverage",
    "link": "https://finance.yahoo.com/news/eli-lilly-brushes-off-cvs-125156949.html"
  },
  {
    "title": "Is Novo Nordisk Stock a Buy?",
    "link": "https://finance.yahoo.com/news/novo-nordisk-stock-buy-104500581.html"
  },
  {
    "title": "Company News for May 2, 2025",
    "link": "https://finance.yahoo.com/news/company-news-may-2-2025-095800842.html"
  },
  {
    "title": "Eli Lilly and Co (LLY) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...",
    "link": "https://finance.yahoo.com/news/eli-lilly-co-lly-q1-071142866.html"
  },
  {
    "title": "Q1 2025 Eli Lilly and Co Earnings Call",
    "link": "https://finance.yahoo.com/news/q1-2025-eli-lilly-co-063053201.html"
  },
  {
    "title": "S&P 500 Gains and Losses Today: Index Rises After Strong Start to Big Tech Earnings",
    "link": "https://finance.yahoo.com/news/p-500-gains-losses-today-202908369.html"
  },
  {
    "title": "Eli Lilly Shares Tumble 10% After Q1 Earnings Miss Wall Street Estimates",
    "link": "https://finance.yahoo.com/news/eli-lilly-shares-tumble-10-194311076.html"
  },
  {
    "title": "Is Eli Lilly and Company (LLY) the Best Growth Stock to Buy for the Next 3 Years?",
    "link": "https://finance.yahoo.com/news/eli-lilly-company-lly-best-191429173.html"
  },
  {
    "title": "Why Eli Lilly (LLY) Stock Is Nosediving",
    "link": "https://finance.yahoo.com/news/why-eli-lilly-lly-stock-184503351.html"
  },
  {
    "title": "Eli Lilly CEO waves off CVS-Novo Nordisk deal: 'It feels a little like last decade'",
    "link": "https://finance.yahoo.com/news/eli-lilly-ceo-waves-off-cvs-novo-nordisk-deal-it-feels-a-little-like-last-decade-184222200.html"
  },
  {
    "title": "3 things we've learned from healthcare earnings",
    "link": "https://finance.yahoo.com/video/3-things-weve-learned-healthcare-180401035.html"
  },
  {
    "title": "Eli Lilly (NYSE:LLY) Reports Strong Q1 Growth Despite Lowered 2025 EPS Guidance",
    "link": "https://finance.yahoo.com/news/eli-lilly-nyse-lly-reports-180259196.html"
  },
  {
    "title": "Lilly’s Q1 2025 revenue jumps 45%, but CVS shift boosts Novo’s Wegovy",
    "link": "https://finance.yahoo.com/news/lilly-q1-2025-revenue-jumps-174447435.html"
  },
  {
    "title": "Lilly star weight-loss drug Zepbound faces coverage challenge from CVS Health",
    "link": "https://finance.yahoo.com/news/lilly-star-weight-loss-drug-170227088.html"
  },
  {
    "title": "Why Eli Lilly Stock Is Sinking Today",
    "link": "https://finance.yahoo.com/news/why-eli-lilly-stock-sinking-164953232.html"
  },
  {
    "title": "Eli Lilly slides, CVS earnings, Qualcomm's soft guidance",
    "link": "https://finance.yahoo.com/video/eli-lilly-slides-cvs-earnings-161935240.html"
  },
  {
    "title": "'Declare victory and move on': Eli Lilly CEO on Trump tariff threat",
    "link": "https://finance.yahoo.com/news/declare-victory-and-move-on-eli-lilly-ceo-on-trump-tariff-threat-160646465.html"
  },
  {
    "title": "Top Midday Stories: Microsoft, Meta Earnings Top Estimates; Eli Lilly Cuts Guidance Despite Strong Q1 Earnings",
    "link": "https://finance.yahoo.com/news/top-midday-stories-microsoft-meta-155528986.html"
  },
  {
    "title": "LLY's Q1 Earnings Miss, Mounjaro & Zepbound Drive Sales, Stock Down",
    "link": "https://finance.yahoo.com/news/llys-q1-earnings-miss-mounjaro-155100125.html"
  },
  {
    "title": "Why the Eli Lilly sell-off may be an 'overreaction'",
    "link": "https://finance.yahoo.com/video/why-eli-lilly-sell-off-155031468.html"
  },
  {
    "title": "Eli Lilly CEO Urges Trump to Ease Up on Tariffs, Extend 2017 Tax Cuts",
    "link": "https://finance.yahoo.com/m/4b159ce0-28d9-3ffe-8614-0d54c1a7e2ae/eli-lilly-ceo-urges-trump-to.html"
  },
  {
    "title": "Initial Claims More Than Expectations",
    "link": "https://finance.yahoo.com/news/initial-claims-more-expectations-150900489.html"
  },
  {
    "title": "Eli Lilly's Q1 win outweighed by Novo's CVS deal",
    "link": "https://finance.yahoo.com/video/eli-lillys-q1-win-outweighed-140954770.html"
  },
  {
    "title": "Eli Lilly Earnings Beat Expectations. Why the Stock Is Falling.",
    "link": "https://finance.yahoo.com/m/0568b560-5011-321d-817f-c1d3f74d68ee/eli-lilly-earnings-beat.html"
  },
  {
    "title": "Here's What Key Metrics Tell Us About Lilly (LLY) Q1 Earnings",
    "link": "https://finance.yahoo.com/news/heres-key-metrics-tell-us-133036555.html"
  },
  {
    "title": "Eli Lilly Lowers 2025 Earnings Outlook Despite Stronger-Than-Expected First-Quarter Results",
    "link": "https://finance.yahoo.com/news/eli-lilly-lowers-2025-earnings-130652292.html"
  },
  {
    "title": "Eli Lilly stock slips despite earnings beat, reaffirmed 2025 guidance",
    "link": "https://finance.yahoo.com/news/eli-lilly-stock-slips-despite-earnings-beat-reaffirmed-2025-guidance-125448495.html"
  },
  {
    "title": "If A Recession Hits, Will Medical Stocks Be A Safe Haven For Investors — Again?",
    "link": "https://finance.yahoo.com/m/d615c35b-9343-3e67-975a-923b1fe5cf7b/if-a-recession-hits-will.html"
  },
  {
    "title": "Lower Taxes Could Bring More Drug Production to U.S., Says Eli Lilly",
    "link": "https://finance.yahoo.com/m/057a2c94-cd1c-3afb-bcbc-dfbfaabe511f/lower-taxes-could-bring-more.html"
  },
  {
    "title": "Eli Lilly (LLY) Q1 Earnings Lag Estimates",
    "link": "https://finance.yahoo.com/news/eli-lilly-lly-q1-earnings-115506741.html"
  },
  {
    "title": "Eli Lilly (NYSE:LLY) Beats Q1 Sales Targets",
    "link": "https://finance.yahoo.com/news/eli-lilly-nyse-lly-beats-114819224.html"
  },
  {
    "title": "Eli Lilly Revenue Up on Demand for Mounjaro, Other Weight-Loss Meds",
    "link": "https://finance.yahoo.com/m/481e4c33-cb1e-3e7a-bb1d-403b3a1fcebb/eli-lilly-revenue-up-on.html"
  },
  {
    "title": "Eli Lilly Stock Drops as Lowered Profit Outlook Outweighs Solid Q1 Results",
    "link": "https://finance.yahoo.com/news/eli-lilly-stock-slips-lowered-111022972.html"
  },
  {
    "title": "Lilly: Q1 Earnings Snapshot",
    "link": "https://finance.yahoo.com/news/lilly-q1-earnings-snapshot-105817352.html"
  },
  {
    "title": "Eli Lilly downplays CVS move to drop Zepbound coverage, shares plunge",
    "link": "https://finance.yahoo.com/news/eli-lilly-beats-q1-profit-105334205.html"
  },
  {
    "title": "Lilly reports first-quarter 2025 financial results and highlights pipeline momentum",
    "link": "https://finance.yahoo.com/news/lilly-reports-first-quarter-2025-104500297.html"
  },
  {
    "title": "CVS posts Q1 earnings beat, raises full-year guidance",
    "link": "https://finance.yahoo.com/news/cvs-posts-q1-earnings-beat-raises-full-year-guidance-103035785.html"
  },
  {
    "title": "Trump Says Tariffs Politically Risky, But He’s Not Rushing Deals",
    "link": "https://finance.yahoo.com/news/trump-says-tariffs-politically-risky-014826903.html"
  },
  {
    "title": "Eli Lilly and Company (LLY): Jim Cramer Rides the GLP-1 Wave — “Hundreds of Thousands Are Filling Scripts Weekly”",
    "link": "https://finance.yahoo.com/news/eli-lilly-company-lly-jim-000250512.html"
  },
  {
    "title": "Amazon and Apple earnings coverage, Eli Lilly: What to Watch",
    "link": "https://finance.yahoo.com/video/amazon-apple-earnings-coverage-eli-230052060.html"
  },
  {
    "title": "Buy Hims (HIMS) or Novo Nordisk (NVO) Stock After Partnership Announcement?",
    "link": "https://finance.yahoo.com/news/buy-hims-hims-novo-nordisk-204800585.html"
  },
  {
    "title": "Viagra and Mounjaro panic-buying could be behind a 200% export surge from Ireland to the U.S.",
    "link": "https://finance.yahoo.com/news/viagra-mounjaro-panic-buying-could-112525070.html"
  },
  {
    "title": "Eli Lilly's Stock Is Up 15% This Year, and Here's Why It Could Take Off Even More",
    "link": "https://finance.yahoo.com/news/eli-lillys-stock-15-heres-095000833.html"
  },
  {
    "title": "Why New Wegovy Deals Won’t Restore Novo Nordisk’s Obesity Lead",
    "link": "https://finance.yahoo.com/news/why-wegovy-deals-won-t-093000116.html"
  },
  {
    "title": "Myostatin inhibitors target muscle loss prevention to fill gap in GLP-1RA market",
    "link": "https://finance.yahoo.com/news/myostatin-inhibitors-target-muscle-loss-080000028.html"
  },
  {
    "title": "What To Expect From Eli Lilly’s (LLY) Q1 Earnings",
    "link": "https://finance.yahoo.com/news/expect-eli-lilly-lly-q1-070801413.html"
  },
  {
    "title": "Hims & Hers Stock Surges on Wegovy Deal With Novo Nordisk",
    "link": "https://finance.yahoo.com/news/hims-hers-stock-surges-wegovy-163634493.html"
  },
  {
    "title": "INCY Q1 Earnings & Revenues Beat Estimates on Higher Product Sales",
    "link": "https://finance.yahoo.com/news/incy-q1-earnings-revenues-beat-150400883.html"
  },
  {
    "title": "Pfizer offers 'longer-term' opportunity amid tariff uncertainty",
    "link": "https://finance.yahoo.com/video/pfizer-offers-longer-term-opportunity-143115195.html"
  },
  {
    "title": "Novo Nordisk Before Q1 Earnings: How Should Investors Play the Stock?",
    "link": "https://finance.yahoo.com/news/novo-nordisk-q1-earnings-investors-142000791.html"
  },
  {
    "title": "Hims & Hers stock jumps on Novo Nordisk GLP-1 partnership",
    "link": "https://finance.yahoo.com/news/hims--hers-stock-jumps-on-novo-nordisk-glp-1-partnership-141811461.html"
  },
  {
    "title": "Jim Cramer on Eli Lilly and Company (LLY): “Riding the wave of GLP-1 success” – Ready to Rebound After a Rare Miss",
    "link": "https://finance.yahoo.com/news/jim-cramer-eli-lilly-company-123821312.html"
  },
  {
    "title": "Is Eli Lilly and Company (LLY) the Best Long-Term Dividend Stock to Buy According to Billionaires?",
    "link": "https://finance.yahoo.com/news/eli-lilly-company-lly-best-123552841.html"
  },
  {
    "title": "Novo partners with telehealth companies in move to expand Wegovy market",
    "link": "https://finance.yahoo.com/news/novo-partners-telehealth-companies-move-121000026.html"
  },
  {
    "title": "Pfizer (PFE) Surpasses Q1 Earnings Estimates",
    "link": "https://finance.yahoo.com/news/pfizer-pfe-surpasses-q1-earnings-115504229.html"
  },
  {
    "title": "Eli Lilly Stock Gets a Double Downgrade. Where Weight-Loss Drugs Go From Here.",
    "link": "https://finance.yahoo.com/m/d5443dea-5f1f-3c71-83e8-da98d13ae0f5/eli-lilly-stock-gets-a-double.html"
  },
  {
    "title": "Pfizer reports mixed results in first quarter earnings, reiterates 2025 outlook",
    "link": "https://finance.yahoo.com/news/pfizer-reports-mixed-results-in-first-quarter-earnings-reiterates-2025-outlook-105736856.html"
  },
  {
    "title": "The Zacks Analyst Blog Highlights Pfizer, Eli Lilly, Amgen, Biogen and Regeneron",
    "link": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-pfizer-103200684.html"
  },
  {
    "title": "Stocks Rise in Final Hour of Wall Street Trading: Markets Wrap",
    "link": "https://finance.yahoo.com/news/asian-investors-eye-china-trade-233327069.html"
  },
  {
    "title": "Will These 5 Big Drug Stocks Surpass Q1 Earnings Forecasts?",
    "link": "https://finance.yahoo.com/news/5-big-drug-stocks-surpass-160800036.html"
  },
  {
    "title": "Is Eli Lilly Stock a Portfolio Must-Have Pre-Q1 Earnings? (Revised)",
    "link": "https://finance.yahoo.com/news/eli-lilly-stock-portfolio-must-154100329.html"
  },
  {
    "title": "HSBC cuts biotech stocks: Eli Lilly lowered to Reduce",
    "link": "https://finance.yahoo.com/news/hsbc-cuts-biotech-stocks-eli-153753390.html"
  },
  {
    "title": "Eli Lilly, Pfizer Risk Billions in Losses From Trump's 25% Pharma Tariffs",
    "link": "https://finance.yahoo.com/news/eli-lilly-pfizer-risk-billions-152037442.html"
  },
  {
    "title": "Boeing, Jack in the Box, Eli Lilly: Trending Tickers",
    "link": "https://finance.yahoo.com/video/boeing-jack-box-eli-lilly-141316547.html"
  },
  {
    "title": "Ahead of Lilly (LLY) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics",
    "link": "https://finance.yahoo.com/news/ahead-lilly-lly-q1-earnings-131604720.html"
  },
  {
    "title": "Is Eli Lilly Stock a Portfolio Must-Have Pre-Q2 Earnings?",
    "link": "https://finance.yahoo.com/news/eli-lilly-stock-portfolio-must-114500948.html"
  },
  {
    "title": "Tariff War Draws Investment Warning From $160 Billion Novo Fund",
    "link": "https://finance.yahoo.com/news/160-billion-fund-behind-novo-063000802.html"
  },
  {
    "title": "Eli Lilly and Company (LLY): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential",
    "link": "https://finance.yahoo.com/news/eli-lilly-company-lly-among-190032841.html"
  },
  {
    "title": "Amateur Athletes Are Turning to Ozempic to Raise Their Game",
    "link": "https://finance.yahoo.com/m/1aa57407-13e1-37f5-9d43-4a11bdcbbf8a/amateur-athletes-are-turning.html"
  },
  {
    "title": "Say goodbye to cheap versions of Ozempic and Wegovy",
    "link": "https://finance.yahoo.com/news/goodbye-cheap-versions-ozempic-wegovy-110000027.html"
  },
  {
    "title": "How tariffs impact pharma stocks",
    "link": "https://finance.yahoo.com/video/tariffs-impact-pharma-stocks-220919065.html"
  },
  {
    "title": "Is Eli Lilly and Company (LLY) the Best Stock to Invest in for Long Term?",
    "link": "https://finance.yahoo.com/news/eli-lilly-company-lly-best-202753804.html"
  },
  {
    "title": "Novo Nordisk wins case to kick knockoff Ozempic off the market, but it may not last",
    "link": "https://finance.yahoo.com/news/novo-nordisk-wins-case-to-kick-knockoff-ozempic-off-the-market-but-it-may-not-last-184547572.html"
  },
  {
    "title": "Analysts Maintain Buy Ratings on Eli Lilly Stock (LLY) as Q1 Earnings Loom",
    "link": "https://finance.yahoo.com/news/analysts-maintain-buy-ratings-eli-130611302.html"
  },
  {
    "title": "AbbVie (ABBV) Q1 Earnings and Revenues Beat Estimates",
    "link": "https://finance.yahoo.com/news/abbvie-abbv-q1-earnings-revenues-125502278.html"
  },
  {
    "title": "The Best Stock to Buy With Less Than $60 in the Market Sell-Off",
    "link": "https://finance.yahoo.com/news/best-stock-buy-less-60-100300668.html"
  },
  {
    "title": "Trending tickers: Alphabet, Intel, Meta, Novo Nordisk and WPP",
    "link": "https://finance.yahoo.com/news/alphabet-intel-meta-novo-nordisk-and-wpp-trending-tickers-095809626.html"
  },
  {
    "title": "Stocks to watch this week: Apple, Microsoft, Shell, HSBC, Lloyds and AstraZeneca",
    "link": "https://finance.yahoo.com/news/apple-microsoft-shell-hsbc-lloyds-astrazeneca-stocks-to-watch-050019911.html"
  },
  {
    "title": "PFE vs. LLY: Which Stock Should Value Investors Buy Now?",
    "link": "https://finance.yahoo.com/news/pfe-vs-lly-stock-value-154005499.html"
  },
  {
    "title": "Roche's Q1 Sales Increase Y/Y on Solid Performance of Key Drugs",
    "link": "https://finance.yahoo.com/news/roches-q1-sales-increase-y-153700491.html"
  },
  {
    "title": "Novo Nordisk Plunges 17% in a Month: Buy, Sell or Hold the Stock?",
    "link": "https://finance.yahoo.com/news/novo-nordisk-plunges-17-month-151800238.html"
  },
  {
    "title": "Eli Lilly Stock Soars on Weight-Loss News. Why It’s Bad for Novo Nordisk.",
    "link": "https://finance.yahoo.com/m/7aff05bf-d49a-32c8-b5e0-7a3138e5c516/eli-lilly-stock-soars-on.html"
  },
  {
    "title": "Eli Lilly (LLY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release",
    "link": "https://finance.yahoo.com/news/eli-lilly-lly-earnings-expected-140156989.html"
  },
  {
    "title": "Jim Cramer Calls Eli Lilly and Company (LLY) a ‘Game Changer’ After Obesity Pill Trial Success",
    "link": "https://finance.yahoo.com/news/jim-cramer-calls-eli-lilly-012222833.html"
  },
  {
    "title": "Eli Lilly sues Mochi Health and others for ‘deceptive’ tirzepatide marketing",
    "link": "https://finance.yahoo.com/news/eli-lilly-sues-mochi-health-180142310.html"
  },
  {
    "title": "Eli Lilly is stepping up its fight against copycat weight loss drugs",
    "link": "https://finance.yahoo.com/news/eli-lilly-stepping-fight-against-161400283.html"
  },
  {
    "title": "Top Midday Stories: Boeing to Ask FAA to Lift Production Cap; Musk Says His Government Commitment to 'Drop Significantly'",
    "link": "https://finance.yahoo.com/news/top-midday-stories-boeing-ask-160244574.html"
  },
  {
    "title": "Is Eli Lilly and Company (LLY) the Best Stock That Will Always Grow?",
    "link": "https://finance.yahoo.com/news/eli-lilly-company-lly-best-141853080.html"
  },
  {
    "title": "Forget Zepbound: Eli Lilly Has Its Next Billion-Dollar Weight Loss Drug",
    "link": "https://finance.yahoo.com/news/forget-zepbound-eli-lilly-next-135300527.html"
  },
  {
    "title": "Is Eli Lilly Stock Going to $900? 1 Wall Street Analyst Thinks So.",
    "link": "https://finance.yahoo.com/news/eli-lilly-stock-going-900-105500384.html"
  },
  {
    "title": "Novo Nordisk Investors Just Got Terrible News. Should You Sell the Stock?",
    "link": "https://finance.yahoo.com/news/novo-nordisk-investors-just-got-095000208.html"
  },
  {
    "title": "Lilly sues four compounders over copies of weight-loss drugs",
    "link": "https://finance.yahoo.com/news/lilly-sues-four-compounders-over-091445810.html"
  },
  {
    "title": "Is Eli Lilly Stock a Buy?",
    "link": "https://finance.yahoo.com/news/eli-lilly-stock-buy-090700444.html"
  },
  {
    "title": "Eli Lilly (LLY) Ascends But Remains Behind Market: Some Facts to Note",
    "link": "https://finance.yahoo.com/news/eli-lilly-lly-ascends-remains-214515636.html"
  },
  {
    "title": "Novo Nordisk Pops After Leapfrogging Eli Lilly With An Obesity Pill",
    "link": "https://finance.yahoo.com/m/e688a2ac-055a-3925-abe7-cd3cb5566982/novo-nordisk-pops-after.html"
  },
  {
    "title": "Q1 Earnings Season Scorecard and Analyst Reports for NVIDIA, Alphabet & Berkshire Hathaway",
    "link": "https://finance.yahoo.com/news/q1-earnings-season-scorecard-analyst-174200345.html"
  },
  {
    "title": "Eli Lilly, Vertex, AbbVie, and More Pharma Stocks to Own as Tariffs Loom",
    "link": "https://finance.yahoo.com/m/c624f5c7-9427-3beb-9308-f1a701d24813/eli-lilly-vertex-abbvie-.html"
  },
  {
    "title": "3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold",
    "link": "https://finance.yahoo.com/news/3-relatively-safe-healthcare-growth-135300768.html"
  },
  {
    "title": "Cantor initiates coverage of U.S. large-cap pharma stocks: Gilead, AbbVie at Buy",
    "link": "https://finance.yahoo.com/news/cantor-initiates-coverage-u-large-134801368.html"
  },
  {
    "title": "Best Leveraged ETFs of Last Week",
    "link": "https://finance.yahoo.com/news/best-leveraged-etfs-last-week-120700507.html"
  },
  {
    "title": "These companies have announced their intention to increase US manufacturing amid Trump's first 100 days",
    "link": "https://finance.yahoo.com/news/companies-announced-intention-increase-us-110041557.html"
  },
  {
    "title": "Novo Nordisk Shares Fall After Data From New Eli Lilly Pill",
    "link": "https://finance.yahoo.com/m/27548f44-a5be-32cf-bda5-d41f7fca59ee/novo-nordisk-shares-fall.html"
  },
  {
    "title": "Novo shares down on Eli Lilly’s positive obesity pill data",
    "link": "https://finance.yahoo.com/news/novo-shares-down-eli-lilly-083401896.html"
  },
  {
    "title": "Novo Nordisk Drops on Weight-Loss Study by Rival Lilly",
    "link": "https://finance.yahoo.com/video/novo-nordisk-drops-weight-loss-075008702.html"
  },
  {
    "title": "These Stocks Moved the Most Today: Tesla, Nvidia, Amazon, Netflix, Discover, Salesforce, UnitedHealth, and More",
    "link": "https://finance.yahoo.com/m/a9118993-25f1-3b30-beee-58f562ad5dca/these-stocks-moved-the-most.html"
  },
  {
    "title": "Eli Lilly and Company (LLY): Among the Best American Dividend Stocks to Buy According to Analysts",
    "link": "https://finance.yahoo.com/news/eli-lilly-company-lly-among-142200345.html"
  },
  {
    "title": "Down 61%, Is Novo Nordisk Stock Worth Buying on the Dip?",
    "link": "https://finance.yahoo.com/news/down-61-novo-nordisk-stock-131500719.html"
  },
  {
    "title": "Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know",
    "link": "https://finance.yahoo.com/news/eli-lilly-company-lly-attracting-130016150.html"
  },
  {
    "title": "LLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III Study",
    "link": "https://finance.yahoo.com/news/lly-stock-oral-glp-1-123700472.html"
  },
  {
    "title": "Healthcare ETFs Tug of War: Insurers Tumble, Pharma Surges",
    "link": "https://finance.yahoo.com/news/healthcare-etfs-tug-war-insurers-123000090.html"
  },
  {
    "title": "Strength Seen in Lilly (LLY): Can Its 14.3% Jump Turn into More Strength?",
    "link": "https://finance.yahoo.com/news/strength-seen-lilly-lly-14-121700546.html"
  },
  {
    "title": "Did Eli Lilly Just Say Checkmate to Novo Nordisk?",
    "link": "https://finance.yahoo.com/news/did-eli-lilly-just-checkmate-083000740.html"
  },
  {
    "title": "Can anything threaten Novo and Lilly’s obesity market dominance?",
    "link": "https://finance.yahoo.com/news/anything-threaten-novo-lilly-obesity-080000858.html"
  },
  {
    "title": "Prediction: Eli Lilly's Newest GLP-1 Drug Will Be a Game-Changer for the Stock",
    "link": "https://finance.yahoo.com/news/prediction-eli-lillys-newest-glp-102000325.html"
  },
  {
    "title": "Is Eli Lilly Stock a Buy Right Now?",
    "link": "https://finance.yahoo.com/news/eli-lilly-stock-buy-now-200500665.html"
  },
  {
    "title": "Is Eli Lilly and Company (LLY) the Best Low Volatility Stock to Buy Now?",
    "link": "https://finance.yahoo.com/news/eli-lilly-company-lly-best-190944035.html"
  },
  {
    "title": "Eli Lilly's Experimental Weight Loss Pill Succeeded in Its First Pivotal Trial. Is It Time to Buy?",
    "link": "https://finance.yahoo.com/news/eli-lillys-experimental-weight-loss-072300907.html"
  },
  {
    "title": "The Score: UnitedHealth, Netflix, Eli Lilly and More Stocks That Defined the Week",
    "link": "https://finance.yahoo.com/m/aa4d6755-3047-3dc8-9fa9-a974897e8997/the-score-unitedhealth-.html"
  },
  {
    "title": "Wall Street Trims Ratings for Novo Nordisk Stock, as Ozempic’s Competition Grows",
    "link": "https://finance.yahoo.com/m/28a69182-f847-3ee7-931e-eec5a42b85b9/wall-street-trims-ratings-for.html"
  },
  {
    "title": "Eli Lilly (NYSE:LLY) Advances Diabetes Treatment And Partners With BigHat On Antibody Discovery",
    "link": "https://finance.yahoo.com/news/eli-lilly-nyse-lly-advances-172602496.html"
  },
  {
    "title": "Eli Lilly promises to make new weight loss pill in the U.S.",
    "link": "https://finance.yahoo.com/news/eli-lilly-promises-weight-loss-171400629.html"
  },
  {
    "title": "H.C. Wainwright still expects Viking to ‘differentiate’ after Lilly data",
    "link": "https://finance.yahoo.com/news/h-c-wainwright-still-expects-155511034.html"
  },
  {
    "title": "Eli Lilly Vows to Make Weight-Loss Pill in U.S. as Trump Pushes for Domestic Manufacturing",
    "link": "https://finance.yahoo.com/m/b4a8d441-7b76-3439-8931-95516655ebcc/eli-lilly-vows-to-make.html"
  },
  {
    "title": "Eli Lilly jumps as results from weight-loss pill study rival competitor’s",
    "link": "https://finance.yahoo.com/news/eli-lilly-jumps-results-weight-152513807.html"
  },
  {
    "title": "Eli Lilly and BigHat Biosciences ink AI antibody discovery deal",
    "link": "https://finance.yahoo.com/news/eli-lilly-bighat-biosciences-ink-151616667.html"
  },
  {
    "title": "Eli Lilly and Company (LLY): One of the Best Long Term Stocks to Buy According to Billionaires",
    "link": "https://finance.yahoo.com/news/eli-lilly-company-lly-one-142949595.html"
  },
  {
    "title": "JPMorgan says Lilly data ‘highly favorable’ for Structure Therapeutics",
    "link": "https://finance.yahoo.com/news/jpmorgan-says-lilly-data-highly-142608655.html"
  },
  {
    "title": "Why Eli Lilly and Company (LLY) is Skyrocketing?",
    "link": "https://finance.yahoo.com/news/why-eli-lilly-company-lly-063152727.html"
  },
  {
    "title": "S&P 500 Gains and Losses Today: UnitedHealth Stock Drops After Earnings Miss, Guidance Cut",
    "link": "https://finance.yahoo.com/news/p-500-gains-losses-today-210817220.html"
  },
  {
    "title": "UnitedHealth Woes Aren’t Dragging Down the Entire Sector. Here’s Why.",
    "link": "https://finance.yahoo.com/m/72e966e2-d8bd-30e8-a6bd-60e44a78d95e/unitedhealth-woes-aren%E2%80%99t.html"
  },
  {
    "title": "How Eli Lilly's GLP-1 pill could transform the weight-loss space",
    "link": "https://finance.yahoo.com/video/eli-lillys-glp-1-pill-202940776.html"
  },
  {
    "title": "Stocks Rebound Fizzles as Trump Goes on Offensive: Markets Wrap",
    "link": "https://finance.yahoo.com/news/asian-stocks-advance-yen-weakens-035657999.html"
  },
  {
    "title": "Eli Lilly Rockets 14% After Solidifying Its Lead For A Weight-Loss Pill",
    "link": "https://finance.yahoo.com/m/5523c7a4-d163-34a1-a4cc-5421457b13c3/eli-lilly-rockets-14-after.html"
  },
  {
    "title": "Equity Markets Mixed as Trump Calls for Interest Rate Cuts",
    "link": "https://finance.yahoo.com/news/equity-markets-mixed-trump-calls-194747920.html"
  },
  {
    "title": "Novo Nordisk downgraded by BMO as Eli Lilly gains ground in weight-loss drug race",
    "link": "https://finance.yahoo.com/news/novo-nordisk-downgraded-bmo-eli-184129564.html"
  },
  {
    "title": "Lilly’s First Pill for Diabetes, Weight Loss Shows Positive Study Results",
    "link": "https://finance.yahoo.com/m/87ad5abc-1045-3a32-aaeb-f36bb20a8dd1/lilly%E2%80%99s-first-pill-for.html"
  },
  {
    "title": "UnitedHealth Sell-Off Drags Dow Lower Intraday; Markets Weigh Trump's Remarks",
    "link": "https://finance.yahoo.com/news/unitedhealth-sell-off-drags-dow-182602666.html"
  },
  {
    "title": "Novo Nordisk Stock Drops on Eli Lilly Oral Weight-Loss Drug Success, Downgrade",
    "link": "https://finance.yahoo.com/news/novo-nordisk-stock-drops-eli-175412305.html"
  },
  {
    "title": "Eli Lilly (NYSE:LLY) Partners With BigHat And Achieves Phase 3 Success With Orforglipron",
    "link": "https://finance.yahoo.com/news/eli-lilly-nyse-lly-partners-173043149.html"
  },
  {
    "title": "Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide",
    "link": "https://finance.yahoo.com/news/why-eli-lilly-stock-soaring-164628539.html"
  },
  {
    "title": "Top Stock Movers Now: UnitedHealth, Nvidia, Eli Lilly and More",
    "link": "https://finance.yahoo.com/news/top-stock-movers-now-unitedhealth-164546291.html"
  },
  {
    "title": "Eli Lilly’s shares up as oral GLP-1RA scores in first Phase III trial",
    "link": "https://finance.yahoo.com/news/eli-lilly-shares-oral-glp-161722127.html"
  },
  {
    "title": "Why Is Eli Lilly (LLY) Stock Rocketing Higher Today",
    "link": "https://finance.yahoo.com/news/why-eli-lilly-lly-stock-160125843.html"
  },
  {
    "title": "Top Midday Stories: Google Found Liable on 3 of 4 Counts in Antitrust Case; UnitedHealth Shares Tumble on Revenue Miss, Guidance Cut",
    "link": "https://finance.yahoo.com/news/top-midday-stories-google-found-155414617.html"
  },
  {
    "title": "Eli Lilly's weight loss pill could be just as good as Ozempic — and the stock soars",
    "link": "https://finance.yahoo.com/news/eli-lillys-weight-loss-pill-152045475.html"
  },
  {
    "title": "UnitedHealth tumbles, Eli Lilly climbs, TSMC holds outlook",
    "link": "https://finance.yahoo.com/video/unitedhealth-tumbles-eli-lilly-climbs-151538903.html"
  },
  {
    "title": "Eli Lilly and Company (LLY): Among the Innovative Healthcare Stocks to Watch in 2025",
    "link": "https://finance.yahoo.com/news/eli-lilly-company-lly-among-145829927.html"
  },
  {
    "title": "Eli Lilly Soars as Oral Diabetes Pill Hits Targets in Phase 3",
    "link": "https://finance.yahoo.com/news/eli-lilly-soars-oral-diabetes-145448425.html"
  },
  {
    "title": "Eli Lilly Investigational Obesity Pill Helps Control Glucose Levels, Reduce Weight; Shares Rally",
    "link": "https://finance.yahoo.com/news/eli-lilly-investigational-obesity-pill-144839390.html"
  },
  {
    "title": "Eli Lilly Shares Soar After Phase 3 Trial Success for Oral Type 2 Diabetes Pill",
    "link": "https://finance.yahoo.com/news/eli-lilly-shares-soar-phase-143917473.html"
  },
  {
    "title": "Eli Lilly stock soars on positive weight-loss pill results",
    "link": "https://finance.yahoo.com/video/eli-lilly-stock-soars-positive-141826651.html"
  },
  {
    "title": "Novo Nordisk shares slump following Eli Lilly’s weight-loss pill success",
    "link": "https://finance.yahoo.com/news/novo-nordisk-shares-slump-following-140751424.html"
  },
  {
    "title": "Update: Eli Lilly Shares Rise as Potential Diabetes Treatment Meets Primary, Secondary Endpoints",
    "link": "https://finance.yahoo.com/news/eli-lilly-shares-rise-potential-140615656.html"
  },
  {
    "title": "Lilly confirms date and conference call for first-quarter 2025 financial results announcement",
    "link": "https://finance.yahoo.com/news/lilly-confirms-date-conference-call-140000602.html"
  },
  {
    "title": "Lilly's Weight-Loss Pill Shocks Wall Street",
    "link": "https://finance.yahoo.com/news/lillys-weight-loss-pill-shocks-130518909.html"
  },
  {
    "title": "1 S&P 500 Stock for Long-Term Investors and 2 to Turn Down",
    "link": "https://finance.yahoo.com/news/1-p-500-stock-long-130231977.html"
  },
  {
    "title": "Eli Lilly Stock Soars on Oral Weight-Loss Drug Trial Results",
    "link": "https://finance.yahoo.com/news/eli-lilly-stock-soars-oral-130021807.html"
  },
  {
    "title": "Top Premarket Gainers",
    "link": "https://finance.yahoo.com/news/top-premarket-gainers-124911273.html"
  },
  {
    "title": "Why Eli Lilly and Company (LLY) Is Among the Best Blue Chip Stocks to Buy According to Billionaires",
    "link": "https://finance.yahoo.com/news/why-eli-lilly-company-lly-122046232.html"
  },
  {
    "title": "Eli Lilly shares jump 14% on positive results for its ’Ozempic in a pill’",
    "link": "https://finance.yahoo.com/news/eli-lilly-shares-jump-12-114624413.html"
  },
  {
    "title": "Eli Lilly Potential Diabetes Treatment Meets Primary, Secondary Endpoints",
    "link": "https://finance.yahoo.com/news/eli-lilly-potential-diabetes-treatment-110521409.html"
  },
  {
    "title": "Lilly weight-loss pill works as well as Ozempic, shares surge",
    "link": "https://finance.yahoo.com/news/lilly-pill-leads-7-9-105026535.html"
  },
  {
    "title": "Eli Lilly's Mounjaro Launch Triggers Weight-Loss Drug Craze In India, Novo Nordisk Seeks To Move Up Wegovy Launch",
    "link": "https://finance.yahoo.com/news/eli-lillys-mounjaro-launch-triggers-104526470.html"
  },
  {
    "title": "Lilly's oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial",
    "link": "https://finance.yahoo.com/news/lillys-oral-glp-1-orforglipron-104500810.html"
  },
  {
    "title": "Stock Market Today: Stocks higher on trade talk optimism; Trump attacks Fed",
    "link": "https://finance.yahoo.com/news/stock-market-today-stocks-bounce-095427766.html"
  },
  {
    "title": "Novo Nordisk A/S (NVO): A Bull Case Theory",
    "link": "https://finance.yahoo.com/news/novo-nordisk-nvo-bull-case-183735432.html"
  }
]